SITE009-0120

SITE009 (AUS) › SITE009-0120

SITE009-0120

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE009 (AUS) · Dr. Novak
consented 2026-01-23

enrolled

AEs

2

Serious

0

Dropout signal

–

Adverse events

2

Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-12-19 (study day 140); relationship: RELATED

moderate assessed

Grade 2 Asthenia — outcome: RECOVERED/RESOLVED; onset 2022-08-28 (study day 27); relationship: not assessed

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.